IMMUNE-MEDIATED ENCEPHALITIS

This adverse event was reported 529 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED ENCEPHALITIS:

# Drug Count
0 NIVOLUMAB 168
1 IPILIMUMAB 104
2 CARBOPLATIN 76
3 PACLITAXEL 57
4 CISPLATIN 34
5 BEVACIZUMAB 29
6 DURVALUMAB 24
7 METHYLPREDNISOLONE 18
8 PEMETREXED DISODIUM 18
9 ETOPOSIDE 17
See all common drugs associated with IMMUNE-MEDIATED ENCEPHALITIS

IMMUNE-MEDIATED ENCEPHALITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEVACIZUMAB-MALY 2 0.0100
1 NITAZOXANIDE 1 0.0029
2 IPILIMUMAB 104 0.0024
3 CEMIPLIMAB-RWLC 4 0.0019
4 SENNOSIDES A AND B 3 0.0018
5 NIVOLUMAB 168 0.0017
6 TREMELIMUMAB 7 0.0016
7 VONOPRAZAN FUMARATE 10 0.0012
8 NALDEMEDINE 2 0.0012
9 DURVALUMAB 24 0.0011
See all drugs enriched for association with IMMUNE-MEDIATED ENCEPHALITIS